Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

By sjmartinez • January 8, 2025

Ogawa L, Morinishi C, Multani A, Gaynor P, Beaird OE, Pham C, Schaenman JM. Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Viruses. 2024 Dec 7;16(12):1889. doi: 10.3390/v16121889. PMID: 39772196.

Tags: CMV, foscarnet, immunocompromised, Infectious Diseases, maribavir, Publications, resistance

IRF1 cooperates with ISGF3 or GAF to form innate immune de novo enhancers in macrophages

Chavez C, Lin K, Malveaux A, Gorin A, Brizuela S, Cheng QJ, Hoffmann A. IRF1 cooperates with ISGF3 or GAF to form innate immune de[...]

The Benefits of COVID-19 Vaccination for Pregnant Patients Hospitalized with Respiratory Symptoms: A Retrospective Cohort Study in South Brazil

Hernandez CJ, Sundar KG, Echegaray F, Cambou MC, Yang LZ, Segura ER, Gonçalves de Melo M, Santos BR, Varella IRDS, Nielsen-Saines K. The Benefits of[...]

Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication

Blair CS, Shoptaw SJ. Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication. Top Antivir Med. 2024 Dec 23;32(5):571-578. PMID: 39765236.